Master dataINID | Criterion | Field | Content |
---|
| Type of IP right | SART | Protection certificate |
| Status | ST | Not pending/lapsed |
21 | DE file number | DAKZ | 12 2007 000 062.6 |
| Use | VZ | Medicinal products |
95 | Product name | TIEZ | Telbivudine und die pharmazeutisch verträglichen Salze davon |
54 | Title of basic patent | TIGZ | BETA-L-2'-DEOXYNUKLEOSIDE FÜR DIE BEHANDLUNG VON HEPATITIS B VIRUS |
51 | IPC main class | ICM (ICMV) | C07H 19/06 (2006.01) |
51 | IPC secondary class(es) | ICS (ICSV) | C07H 19/10 (2006.01), C07H 19/16 (2006.01), C07H 19/20 (2006.01), A61K 31/70 (2006.01), A61P 31/12 (2006.01) |
94 | Start of term of protection | LB | Aug 11, 2019 |
94 | End of term of protection | LE | Apr 26, 2022 |
22 | DE application date | DAT | Sep 20, 2007 |
| Date of publication of application for a certificate | OT | Dec 20, 2007 |
| Date of publication of grant of certificate | PET | Feb 21, 2013 |
71/73 | Applicant/owner | INH | Centre National de la Recherche Scientifique, 3 rue Michel Ange, Cédex 16, 75794 Paris, FR; Novartis AG, Lichtstr. 35, 4056 Basel, CH; Université de Montpellier, 163 Auguste Broussonnet, 34090 Montpellier, FR |
74 | Representative | VTR | IP2 Patentanwalts GmbH, 41238 Mönchengladbach, DE |
| Address for service | | IP2 Patentanwalts GmbH, 41238 Mönchengladbach, DE |
| Patent division in charge | | 44 |
68 | DE file number of basic patent | GAKZ | 699 29 060.0 |
68 | EP file number of basic patent | GEAKZ | 99 94 1027.7 |
43 | Date of first publication | EVT | Dec 20, 2007 |
92 92 92
| Domestic authorisation | GIS GIN GIT
| Europäische Kommission EU /1/07/388/001 2007-04-24
|
93 93 93 93
| EU authorisation | GES GEC GEN GET
| Europäische Kommission EU EU/1/07/388/001 2007-04-24
|
| Date of the first transfer into DPMAregister | EREGT | May 26, 2011 |
| Date of the (most recent) update in DPMAregister | REGT | Aug 6, 2024 (Show all update days)(Hide all update days)- Aug 6, 2024
- St.36: changed (technical change)
- Jun 9, 2022; Apr 28, 2022; Mar 29, 2022; Aug 10, 2021; Aug 13, 2020; Aug 8, 2019; Jul 16, 2019; Feb 1, 2017; Aug 25, 2016; Jul 19, 2016; Apr 5, 2016; Apr 2, 2016; Mar 22, 2016; Mar 17, 2016; Aug 25, 2015; Jul 11, 2015; Jul 6, 2014; May 3, 2014; Mar 1, 2014; Feb 26, 2014; Feb 20, 2014; Feb 18, 2014; Sep 24, 2013; Aug 2, 2013; Jun 13, 2013; May 16, 2013; May 14, 2013; Mar 16, 2013; Feb 21, 2013; Jan 2, 2013; Nov 29, 2012; Oct 29, 2012; Oct 19, 2012; Oct 11, 2012; Oct 10, 2012; Feb 28, 2012; Feb 24, 2012; Feb 23, 2012; Nov 1, 2011; Oct 11, 2011; Oct 7, 2011; 31.05.2011; May 31, 2011
- Historical data not available for this/these date(s)
- May 26, 2011
- Date of the first transfer into DPMAregister
|
View procedures New applicant/owner details (No.: 3)INID | Criterion | Field | Content
Close details
|
---|
| Type of procedure | VART | New applicant/owner details |
| Legal/procedural status | VST | New applicant/owner details |
| Date of legal/procedural status | VSTT | Feb 27, 2012 |
71/73 | Applicant/owner | INH | Centre National de la Recherche Scientifique, 75794 Paris, FR; Idenix Pharmaceuticals, Inc., (n.d.Ges.d. Staates Delaware), 02139 Cambridge, Mass., US; L'Université Montpellier II, 34095 Montpellier, FR |
71/73 | Previous applicant/owner | INHF | L'Universite Montpellier II, Montpellier, FR |
View procedures New applicant/owner details (No.: 4)INID | Criterion | Field | Content
Close details
|
---|
| Type of procedure | VART | New applicant/owner details |
| Legal/procedural status | VST | New applicant/owner details |
| Date of legal/procedural status | VSTT | Oct 9, 2012 |
71/73 | Previous applicant/owner | INHF | Centre National de la Recherche Scientifique, 75794 Paris, FR, Idenix Pharmaceuticals, Inc., (n.d.Ges.d. Staates Delaware), 02139 Cambridge, Mass., US, L'Université Montpellier II, 34095 Montpellier, FR |
View procedures New applicant/owner details (No.: 8)INID | Criterion | Field | Content
Close details
|
---|
| Type of procedure | VART | New applicant/owner details |
| Legal/procedural status | VST | New applicant/owner details |
| Date of legal/procedural status | VSTT | May 15, 2013 |
71/73 | Applicant/owner | INH | Centre National de la Recherche Scientifique, 75794 Paris, FR; Idenix Pharmaceuticals, Inc., (n.d.Ges.d. Staates Delaware), 02139 Cambridge, Mass., US; L'Université Montpellier II, 34095 Montpellier, FR |
71/73 | Previous applicant/owner | INHF | Centre National de la Recherche Scientifique, 75794 Paris, FR, Idenix (Cayman) Ltd., Grand Cayman, Cayman Islands, KY, L'Université Montpellier II, 34095 Montpellier, FR |
View procedures New applicant/owner details (No.: 9)INID | Criterion | Field | Content
Close details
|
---|
| Type of procedure | VART | New applicant/owner details |
| Legal/procedural status | VST | New applicant/owner details |
| Date of legal/procedural status | VSTT | Jun 12, 2013 |
71/73 | Applicant/owner | INH | Centre National de la Recherche Scientifique, 75794 Paris, FR; L'Université Montpellier II, 34095 Montpellier, FR; Novartis AG, 4056 Basel, CH |
71/73 | Previous applicant/owner | INHF | Centre National de la Recherche Scientifique, 75794 Paris, FR, Idenix Pharmaceuticals, Inc., (n.d.Ges.d. Staates Delaware), 02139 Cambridge, Mass., US, L'Université Montpellier II, 34095 Montpellier, FR |
View procedures New applicant/owner details (No.: 10)INID | Criterion | Field | Content
Close details
|
---|
| Type of procedure | VART | New applicant/owner details |
| Legal/procedural status | VST | New applicant/owner details |
| Date of legal/procedural status | VSTT | Aug 1, 2013 |
71/73 | Applicant/owner | INH | Centre National de la Recherche Scientifique, 75794 Paris, FR; L'Université Montpellier II, 34095 Montpellier, FR; Novartis AG, 4056 Basel, CH |
71/73 | Previous applicant/owner | INHF | Centre National de la Recherche Scientifique, 75794 Paris, FR, L'Université Montpellier II, 34095 Montpellier, FR, Novartis AG, 4056 Basel, CH |
View procedures New applicant/owner details (No.: 15)INID | Criterion | Field | Content
Close details
|
---|
| Type of procedure | VART | New applicant/owner details |
| Legal/procedural status | VST | New applicant/owner details |
| Date of legal/procedural status | VSTT | Jan 31, 2017 |
71/73 | Applicant/owner | INH | Centre National de la Recherche Scientifique, 75794 Paris, FR; Novartis AG, 4056 Basel, CH; Université de Montpellier, 34090 Montpellier, FR |
71/73 | Previous applicant/owner | INHF | Centre National de la Recherche Scientifique, 75794 Paris, FR, L'Université Montpellier II, 34095 Montpellier, FR, Novartis AG, 4056 Basel, CH |